Department of Chemistry professor Matthew Disney, PhD, will head the five-year project and work with Leonard Petrucelli, PhD, chair of neuroscience at Mayo Clinic’s Florida campus, and Baltimore-based Johns Hopkins School of Medicine professor Jeffery D. Rothstein, MD.
“Our work has changed the view of what is considered a druggable target, and this grant is a clear recognition of that accomplishment,” Dr. Disney told South Florida Business Journal. “The question we can now try and answer is if these studies can help to advance the science to bring a drug to ALS patients.”
More articles on healthcare finance:
6 largest gifts from individuals to healthcare organizations in 2017
Oregon House narrowly passes $670M healthcare tax package
12 recent hospital, health system outlook and credit rating actions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.